An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gilead Sciences to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Gilead Sciences (NASDAQ: GILD) announced its participation in three upcoming investor conferences. The SVB Securities Global Biopharma Conference will take place on February 14 at 11:20 AM ET. Following this, Gilead will be present at the Cowen Annual Health Care Conference on March 7 at 11:10 AM ET, and the Barclays Global Healthcare Conference on March 15 at 10:15 AM ET. Live webcasts and 30-day replays will be available on the company’s investor page.
Gilead, headquartered in Foster City, California, has been a leader in developing innovative medicines for over three decades.
Positive
None.
Negative
None.
FOSTER CITY, Calif.--(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
SVB Securities Global Biopharma Conference on Tuesday, February 14 at 11:20 AM Eastern Time
Cowen Annual Health Care Conference on Tuesday, March 7 at 11:10 AM Eastern Time
Barclays Global Healthcare Conference on Wednesday, March 15 at 10:15 AM Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
When will Gilead Sciences present at the SVB Securities Global Biopharma Conference?
Gilead Sciences will present at the SVB Securities Global Biopharma Conference on February 14 at 11:20 AM ET.
What is Gilead's participation schedule for March 2023 investor conferences?
In March 2023, Gilead will participate in the Cowen Annual Health Care Conference on March 7 at 11:10 AM ET, and the Barclays Global Healthcare Conference on March 15 at 10:15 AM ET.
Where can I access the live webcasts for Gilead's investor conferences?
Live webcasts for Gilead's investor conferences can be accessed on the company's investors page at investors.gilead.com.
How long will the replay of Gilead's conference presentations be available?
Replays of Gilead's conference presentations will be available for at least 30 days following each event.
What does Gilead Sciences focus on in its research?
Gilead Sciences focuses on developing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, and cancer.
